Square Pharmaceuticals PLC. (DSE:SQURPHARMA)

Bangladesh flag Bangladesh · Delayed Price · Currency is BDT
209.80
+0.80 (0.38%)
At close: Jan 15, 2026
-2.69%
Market Cap185.98B
Revenue (ttm)80.13B
Net Income (ttm)25.28B
Shares Out886.45M
EPS (ttm)28.52
PE Ratio7.36
Forward PEn/a
Dividend12.00 (5.72%)
Ex-Dividend DateNov 17, 2025
Volume911,720
Average Volume480,297
Open209.50
Previous Close209.00
Day's Range209.30 - 211.20
52-Week Range198.00 - 234.10
Beta-0.00
RSI70.49
Earnings DateJan 29, 2026

About DSE:SQURPHARMA

Square Pharmaceuticals PLC., together with its subsidiaries, manufactures, markets, and distributes pharmaceutical products in Bangladesh and internationally. The company offers pharmaceutical products comprising alimentary preparations, amoebocides, analgesics, anthelmintics, anti-aphthous ulcer, anti-erectile dysfunction, anti-gout, anti-hyperkalemia, anti-osteoarthritis, anti-thyroid, anti-ulcerants, antiallergies, antianemics, antiasthma, antibiotics, antidiabetics, antifibrinolytics, antihemorrhoidals, antihistamines, antiosteoporotics, an... [Read more]

Industry Pharmaceutical Preparations
Founded 1958
Employees 15,937
Stock Exchange Dhaka Stock Exchange
Ticker Symbol SQURPHARMA
Full Company Profile

Financial Performance

In 2025, DSE:SQURPHARMA's revenue was 76.29 billion, an increase of 8.83% compared to the previous year's 70.10 billion. Earnings were 23.97 billion, an increase of 14.54%.

Financial Statements

News

There is no news available yet.